PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
NCT06750432
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
144
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease, Early Onset
Interventions
DRUG:
PMN310
DRUG:
Placebo
Sponsor
ProMis Neurosciences, Inc